FDA Inspection 888639 — Cumberland Pharmaceuticals, Inc.
The FDA completed an inspection of Cumberland Pharmaceuticals, Inc. on July 25, 2014 in Nashville, TN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 25, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Nashville, TN (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)